Inhibition of KIT Tyrosine Kinase Activity: Two Decades After the First Approval
J Clin Oncol
.
2021 May 20;39(15):1674-1686.
doi: 10.1200/JCO.20.03245.
Epub 2021 Apr 2.
Authors
Lillian R Klug
1
2
3
,
Christopher L Corless
1
4
,
Michael C Heinrich
1
2
3
Affiliations
1
Oregon Health & Science University, Knight Cancer Institute, Portland, OR.
2
Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR.
3
VA Portland Health Care System, Portland, OR.
4
Department of Pathology, Oregon Health & Science University, Portland, OR.
PMID:
33797935
PMCID:
PMC8274803
DOI:
10.1200/JCO.20.03245
No abstract available
MeSH terms
Humans
Protein-Tyrosine Kinases / metabolism*
Proto-Oncogene Proteins c-kit / metabolism*
Substances
KIT protein, human
Protein-Tyrosine Kinases
Proto-Oncogene Proteins c-kit
Grant support
I01 BX000338/BX/BLRD VA/United States
I01 BX005358/BX/BLRD VA/United States
R21 CA263400/CA/NCI NIH HHS/United States